miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma

Immune checkpoint inhibitors are a promising therapy for the treatment of cancers, including melanoma, that improved benefit clinical outcomes. However, a subset of melanoma patients do not respond or acquire resistance to immunotherapy, which limits their clinical applicability. Recent studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Mai-Huong Thi, Luo, Yueh-Hsia, Li, An-Lun, Tsai, Jen-Chieh, Wu, Kun-Lin, Chung, Pei-Jung, Ma, Nianhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615556/
https://www.ncbi.nlm.nih.gov/pubmed/34827646
http://dx.doi.org/10.3390/biom11111648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615556/
https://www.ncbi.nlm.nih.gov/pubmed/34827646
http://dx.doi.org/10.3390/biom11111648

Ejemplares similares